Advertisement

Immunodeficiency-Associated Lymphoproliferative Disorder

  • Juehua GaoEmail author
  • Yi-Hua Chen
Chapter
Part of the Atlas of Anatomic Pathology book series (AAP)

Abstract

Immunodeficiency-associated lymphoproliferative disorders (LPDs) can occur in the setting of HIV infection, after transplantation (posttransplant lymphoproliferative disorder, PTLD), or in other clinical conditions including primary immunodeficiency or the use of immunosuppressive drugs (iatrogenic immunodeficiency-associated LPD). LPDs in the setting of immunodeficiency share similar morphologic features, with a broad spectrum of findings from polymorphous lymphoplasmacytic proliferations to aggressive lymphoma. In patients diagnosed with an immunodeficiency-associated LPD, a staging bone marrow is recommended as part of the initial workup. This chapter illustrates the common bone marrow findings in immunodeficiency-associated LPD.

Keywords

Immunodeficiency-associated lymphoproliferative disorder Posttransplant HIV Iatrogenic immunodeficiency Bone marrow involvement 

References

  1. 1.
    Corti M, Villafane M, Minue G, Campitelli A, Narbaitz M, Gilardi L. Clinical features of AIDS patients with Hodgkin’s lymphoma with isolated bone marrow involvement: report of 12 cases at a single institution. Cancer Biol Med. 2015;12:41–5.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Ponzoni M, Fumagalli L, Rossi G, Freschi M, Re A, Vigano MG, et al. Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma. Mod Pathol. 2002;15:1273–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Said JW. Immunodeficiency-related Hodgkin lymphoma and its mimics. Adv Anat Pathol. 2007;14:189–94.CrossRefPubMedGoogle Scholar
  4. 4.
    Schommers P, Hentrich M, Hoffmann C, Gillor D, Zoufaly A, Jensen B, et al. Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort. Br J Haematol. 2015;168:806–10.CrossRefPubMedGoogle Scholar
  5. 5.
    Boulanger E, Agbalika F, Maarek O, Daniel MT, Grollet L, Molina JM, et al. A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients. Hematol J. 2001;2:172–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Morrison VA, Dunn DL, Manivel JC, Gajl-Peczalska KJ, Peterson BA. Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med. 1994;97:14–24.CrossRefPubMedGoogle Scholar
  7. 7.
    Maecker B, Jack T, Zimmermann M, Abdul-Khaliq H, Burdelski M, Fuchs A, et al. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation. J Clin Oncol. 2007;25:4902–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Dotti G, Fiocchi R, Motta T, Mammana C, Gotti E, Riva S, et al. Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome. Transplantation. 2002;74:1095–102.CrossRefPubMedGoogle Scholar
  9. 9.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, et al. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment. Haematologica. 2002;87:67–77.PubMedGoogle Scholar
  10. 10.
    Akar Ozkan E, Ozdemir BH, Yilmaz Akcay E, Terzi A, Karakus S, Haberal M. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant. Exp Clin Transplant. 2015;13(Suppl 1):183–7.PubMedGoogle Scholar
  11. 11.
    Hourigan MJ, Doecke J, Mollee PN, Gill DS, Norris D, Johnson DW, et al. A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation. Br J Hematol. 2008;141:904–7.CrossRefGoogle Scholar
  12. 12.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. J Clin Oncol. 2009;27:3354–62.CrossRefPubMedGoogle Scholar
  13. 13.
    Montanari F, O’Connor OA, Savage DG, Zain JM, Venkatraman S, McCormick EK, et al. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors. Hum Pathol. 2010;41(8):1150.CrossRefPubMedGoogle Scholar
  14. 14.
    Koeppen H, Newell K, Baunoch DA, Vardiman JW. Morphologic bone marrow changes in patients with posttransplantation lymphoproliferative disorders. Am J Surg Pathol. 1998;22:208–14.CrossRefPubMedGoogle Scholar
  15. 15.
    Perry AM, Aoun P, Coulter DW, Sanger WG, Grant WJ, Coccia PF. Early onset, EBV(−) PTLD in pediatric liver–small bowel transplantation recipients: a spectrum of plasma cell neoplasms with favorable prognosis. Blood. 2013;121:1377–83.CrossRefPubMedGoogle Scholar
  16. 16.
    Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Sibley RK, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res. 1981;41:4262–79.PubMedGoogle Scholar
  17. 17.
    Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996;14:1943–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Hoshida Y, JX X, Fujita S, Nakamichi I, Ikeda J, Tomita Y, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007;34:322–31.PubMedGoogle Scholar
  19. 19.
    Baptista MJ, Garcia O, Morgades M, Gonzalez-Barca E, Miralles P, Lopez-Guillermo A, et al. HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era. AIDS. 2015;29:811–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Raphael M, Said J, Borisch B, Cesarman E, Harris NL. Lymphomas associated with HIV infection. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: WHO Publications Center; 2008. p. 340–2.Google Scholar
  21. 21.
    Koizumi Y, Uehira T, Ota Y, Ogawa Y, Yajima K, Tanuma J, et al. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases. Int J Hematol. 2016;104:669–81.CrossRefPubMedGoogle Scholar
  22. 22.
    Loghavi S, Alayed K, Aladily TN, Zuo Z, Ng SB, Tang G, et al. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients. J Hematol Oncol. 2015;8:65.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2018

Authors and Affiliations

  1. 1.Department of PathologyNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations